QUOTE AND NEWS
Globe Newswire  Jul 24  Comment 
JERUSALEM, July 24, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received approval from Israel's Ministry of Health to test the efficacy of its Deep TMS (Transcranial Magnetic Stimulation) system as a
Globe Newswire  Jul 3  Comment 
JERUSALEM, July 3, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received interim results with respect to a clinical trial being conducted at the Sheba Medical Center at Tel Hashome to assess the efficacy of
Globe Newswire  Jul 2  Comment 
JERUSALEM, July 2, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received CE Mark enabling commercialization of its Deep TMS system to treat neuropathic chronic pain ("neuropathic pain") in the European Union
Globe Newswire  Apr 18  Comment 
JERUSALEM, April 18, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce positive results from its double-blind multicenter clinical trial for the assessment of the safety and efficacy of Deep Transcranial Magnetic Stimulation
Globe Newswire  Jan 3  Comment 
JERUSALEM, Jan. 3, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that, on January 1st, 2012, it entered into an exclusive agreement for the distribution of the Deep TMS devices with a Chilean company specially formed for
Globe Newswire  Nov 1  Comment 
JERUSALEM, Nov. 1, 2011 (GLOBE NEWSWIRE) -- Further to that stated in Brainsway's (TASE:BRIN) periodic report for 2010, the Company is pleased to announce that it has received an Investigational Device Exemption ("IDE") approval from the U.S. Food
MarketWatch  May 29  Comment 
Israel stocks rose on Sunday, led by strength in Teva Pharmaceutical Industries Ltd. and the tech stocks.





 


References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki